the present invention relates to novel triazolo - pyridines of the formula i wherein r 1 is fluoro ; s is an integer from two to three ; r 2 is cycloalkyl optionally substituted by one or two moieties independently selected from the group consisting of halo , alkyl , hydroxy , alkoxy and alkyl -— o —; or r 2 is alkyl optionally substituted by one or two moieties independently selected from the group consisting of halo , alkyl , hydroxy , alkoxy and alkyl -— o —; with the proviso that said compound of formula i cannot be 6 -- oxazol - 5 - yl ]- 3 - isopropyl - triazolopyridine ; or 6 -- oxazol - 5 - yl ]- 3 - isopropyl - triazolopyridine ; to intermediates for their preparation , to pharmaceutical compositions containing them and to their medicinal use . the compounds of the present invention are potent inhibitors of map kinases , preferably p38 kinase . they are useful in the treatment of inflammation , osteoarthritis , rheumatoid arthritis , cancer , repurfusion or ischemia in stroke or heart attack , autoimmune diseases and other disorders .